Search Tag: Cancer Prognosis
2025 11 Oct
Anticipating postoperative outcomes in oesophageal squamous cell carcinoma (ESCC) remains difficult given frequent relapse and poor prognosis after recurrence. Contrast-enhanced CT contains quantitative information beyond routine visual assessment. By extracting radiomic features from preoperative CT and combining them with clinicopathological...Read more
2025 11 Oct
Anticipating postoperative outcomes in oesophageal squamous cell carcinoma (ESCC) remains difficult given frequent relapse and poor prognosis after recurrence. Contrast-enhanced CT contains quantitative information beyond routine visual assessment. By extracting radiomic features from preoperative CT and combining them with clinicopathological...Read more
2025 11 Oct
Anticipating postoperative outcomes in oesophageal squamous cell carcinoma (ESCC) remains difficult given frequent relapse and poor prognosis after recurrence. Contrast-enhanced CT contains quantitative information beyond routine visual assessment. By extracting radiomic features from preoperative CT and combining them with clinicopathological...Read more
2025 16 Aug
Colorectal cancer is among the most common gastrointestinal malignancies and is the third leading cause of cancer-related mortality worldwide. Stage II disease is characterised by tumours that have not yet spread to lymph nodes or distant organs. Surgery is the primary treatment, yet recurrence occurs in 20–25% of patients after resection, often...Read more
2025 25 Mar
Hepatocellular carcinoma (HCC) is one of the most common and lethal malignancies worldwide, ranking as the third leading cause of cancer-related deaths. Despite advancements in diagnostic and therapeutic approaches, the prognosis for patients with advanced HCC remains poor, with five-year survival rates as low as 18%. A major contributing factor...Read more
2025 25 Mar
Hepatocellular carcinoma (HCC) is one of the most common and lethal malignancies worldwide, ranking as the third leading cause of cancer-related deaths. Despite advancements in diagnostic and therapeutic approaches, the prognosis for patients with advanced HCC remains poor, with five-year survival rates as low as 18%. A major contributing factor...Read more
2025 25 Mar
Image caption: Anonymised head and neck MRI scan for detailed medical imaging and diagnosis. Head and neck squamous cell carcinoma (HNSCC) is a common cancer that contributes to about 4.6% of global cancer deaths, with around 890,000 new cases each year. It primarily affects adults over 50, with a male-to-female incidence ratio of 2:1. Prognosis...Read more
2024 10 Nov
Cervical cancer remains a prominent health challenge worldwide, particularly in its advanced stages, where prognosis is generally poor despite the widespread use of combined chemoradiotherapy. As a fourth leading cause of cancer among women globally, locally advanced cervical cancer sees high rates of recurrence and metastasis even after initial...Read more
2024 17 May
In locally advanced pancreatic cancer (LAPC), preventing local progression is crucial as it significantly impacts survival rates. Intraoperative radiotherapy (IORT) has shown promise in improving local disease control rates. However, determining the risk of progression in patients initially assessed as stable disease (SD) after IORT remains challenging....Read more